Subject
Dermatology,Histology,Pathology and Forensic Medicine
Reference33 articles.
1. Efficacy of apremilast in the treatment of moderate to severe psoriasis: A randomised controlled trial;Papp;Lancet.,2012
2. Apremilast, an oral phosphodiesterase 4 (pde4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase iii, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1);Papp;J Am Acad Dermatol.,2015
3. Efficacy and safety of apremilast, an oral phosphodiesterase 4 inhibitor, in patients with moderate-to-severe plaque psoriasis over 52 weeks: A phase iii, randomized controlled trial (ESTEEM 2);Paul;Br J Dermatol.,2015
4. Tratamiento de la psoriasis del cuero cabelludo. Revisión de la evidencia y Consenso Delphi del Grupo de Psoriasis de la Academia Española de Dermatología y Venereología;Puig;Actas Dermosifiliogr.,2010
5. Fitch K, Bernstein SJ, Aguilar MD, Burnand B, LaCalle JR, Lázaro P, et al. The RAND/UCLA appropriateness method user's manual. Library of Congress Cataloging-in-Publication Data. Santa Monica, CA: RAND; 2001.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献